Advicenne announces positive opinion from the French Transparency Commission (HAS) for its drug SibnayalTM in dRTA
Advicenne announces positive opinion from the French
- SibnayalTM eligible for reimbursement by the French public health insurance system
- ASMR IV: Recognition of the contribution of SibnayalTM in the treatment of dRTA
This decision makes SibnayalTM the only specialty pharmaceutical product reimbursed in the treatment of dRTA in
Distal renal tubular acidosis (dTRA) is an orphan disease characterized by the inabilitý of the kidney to excrete acids from metabolism. The excess of acids in the blood leads to pH imbalance (acidosis) and multiple other complications: growth retardation, bone development and rickets, metabolic abnormalities (decreased blood potassium, elevated urinary calcium), kidney stone formation, calcium deposits in the kidney (calcinosis), renal failure. Whether genetic or acquired, as a consequence of an immunological disease, ATRd is a chronic pathology that affects approximately 30,000 patients in
About
CONTACTS
+33 (0)4 66 05 54 20 Email: [email protected] |
Ulysses Communication Media relations Email: [email protected] |
Email: [email protected] |
Forward-Looking Statements
This press release contains certain forward-looking statements relating to the business of
In some cases, forward-looking statements can be identified by words such as "could," "should," "may," "expects," "anticipates," "believes," "intends," "estimates," "aims," "targets" or similar words. Although the management of
Source:
ARGO GROUP INTERNATIONAL HOLDINGS, LTD. FILES (8-K) Disclosing Regulation FD Disclosure, Financial Statements and Exhibits
Doma Brings Machine Learning Technology to Approximately 83% of US Residential Real Estate Market
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News